SEGALL BRYANT & HAMILL, LLC

Position in PRGO — PERRIGO Co plc

CIK 1006378 CHICAGO, IL

Position in PRGO

as of Jun 30, 2026 · filed Aug 12, 2026 Compact

Position Value

$1,111,013

-$10,187,290 QoQ

Shares Held

106,931

-69.5% QoQ

Ownership

0.077%

of shares outstanding

% of Portfolio

0.01%

of 13F equity value

Holder Rank

#98

of 334 holders

Holding Since

Jun 2022

9 quarters on record

Voting authority Sole 100% Shared 0% None 0%

Healthcare · as of Jun 30, 2026

SEGALL BRYANT & HAMILL, LLC holds $61,046,740 across 14 Drug Manufacturers - Specialty & Generic names. PRGO ranks #9 (1.8% of the industry book) .

#	Ticker	Company	Shares	Value (USD)
1	ALKS	Alkermes plc.	498,222	$26,106,832
2	NBIX	Neurocrine Biosciences Inc	64,908	$10,939,594
3	KNSA	Kiniksa Pharmaceuticals International, plc	71,901	$4,598,068
4	AMRX	Amneal Pharmaceuticals, Inc.	240,060	$4,155,438
5	LQDA	Liquidia Corp	50,802	$4,050,443
6	ANIP	Ani Pharmaceuticals Inc	32,860	$2,720,150
7	IRWD	Ironwood Pharmaceuticals Inc	408,064	$1,717,949
8	SUPN	Supernus Pharmaceuticals, Inc.	25,931	$1,206,050

9 filing rows on record

Report Date	Value (USD)	Shares	Change	Type	Discretion	Filed
2026-06-30	$1,111,013	106,931	-69.5%	Shares	Sole	2026-08-12
2024-03-31	$11,298,303	350,988	-23.4%	Shares	Sole	2024-05-15
2023-12-31	$14,741,883	458,107	-47.9%	Shares	Sole	2024-02-14
2023-09-30	$28,101,303	879,540	+3.9%	Shares	Sole	2023-11-09
2023-06-30	$28,746,924	846,743	+1.0%	Shares	Sole	2023-08-14
2023-03-31	$30,074,448	838,429	-15.2%	Shares	Sole	2023-05-15
2022-12-31	$33,712,998	988,941	-2.8%	Shares	Sole	2023-02-14
2022-09-30	$36,281,018	1,017,415	+48.6%	Shares	Sole	2022-11-14
2022-06-30	$27,768,136	684,450	—	Shares	Sole	2022-08-15
No filing history on record for this holder in this stock.